Accretion Nutraveda IPO Details
| IPO Open Date | January 27, 2026 |
| IPO Close Date | January 30, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹122 to ₹129 Per Share |
| Issue Size | Approx ₹24.77 Crores |
| Fresh Issue | Approx ₹24.77 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Accretion Nutraveda IPO Review & Key Points
- Review:
Accretion Nutraveda IPO Market Lot
The Accretion Nutraveda IPO minimum market lot is 2,000 shares with ₹2,58,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,58,000 |
| Retail Maximum | 2 | 2,000 | ₹2,58,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,87,000 |
| S-HNI Maximum | 7 | 7,000 | ₹9,03,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,32,000 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 9,08,000 Shares | 47.29% |
| NII Shares Offered | 2,76,000 Shares | 14.37% |
| Retail Shares Offered | 6,40,000 Shares | 33.33% |
Accretion Nutraveda IPO Anchor Investors
| Anchor Bidding Date | January, 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | 2026 |
| lock-in period end date 50% shares (90 Days) | 2026 |
Accretion Nutraveda IPO Dates
The Accretion Nutraveda IPO date is January 27 and the close date is January 30. The Accretion Nutraveda IPO allotment will be finalized on February 2 and the IPO listing on February 4.
| IPO Open Date: | January 27, 2026 |
| IPO Close Date: | January 30, 2026 |
| Basis of Allotment: | February 2, 2026 |
| Refunds: | February 3, 2026 |
| Credit to Demat Account: | February 3, 2026 |
| IPO Listing Date: | February 4, 2026 |
| IPO Bidding Cut-off Time: | January 30, 2026 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 53,20,000 | 100% |
| Promoter Holding Post Issue | 72,40,000 | 73.48% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Purchase of Machineries for Automation in existing Manufacturing unit | ₹4.22 |
| Purchase of Machineries for New Manufacturing Setup | ₹8.03 |
| Funding working capital requirements of our company | ₹5.50 |
| General Corporate Purpose | ₹- |
About Accretion Nutraveda IPO
Accretion Nutraveda, since its incorporation in 2021, has been focused on the manufacturing of Ayurvedic and Nutraceutical products in India. It offers Ayurvedic and Nutraceutical products in various dosages and forms, like tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company serves its customers in India as well as in international countries like Sri Lanka, Singapore, and the USA. The firm blends Ayurvedic and science to offer treatments for various areas, like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. The company runs a 10,763 sq. ft. manufacturing facility situated in Gujarat. Its unit includes modern infrastructure and quality control systems.
Accretion Nutraveda IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹3.07 | ₹2.78 | ₹0.28 | ₹4.06 |
| 2024 | ₹5.20 | ₹4.28 | ₹0.82 | ₹4.64 |
| 2025 | ₹16.06 | ₹12.87 | ₹2.61 | ₹10.86 |
Accretion Nutraveda IPO Valuation – FY2025
Check Accretion Nutraveda IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 81.22% |
| ROCE: | 36.98% |
| EBITDA Margin: | 22.79% |
| PAT Margin: | 16.33% |
| Debt to equity ratio: | – |
| Earning Per Share (EPS): | ₹7.19 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 48.85% |
| Net Asset Value (NAV): | ₹14.72 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Walpar Nutritions Ltd. | 1.80 | 23.94 | 11.27% | 13.65 | 60.26 Cr. |
| Influx Healthtech Limited | 7.31 | 25.93 | 36.72% | 5.31 | 104.99 Cr. |
IPO Lead Managers aka Merchant Bankers
- Sobhagya Capital Options Pvt. Ltd.
Company Address
Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi, TaSanand,
Ahmedabad, Gujarat, 382213
Phone: +91- 9904366177
Email: [email protected]
Website: http://www.accretionnutraveda.com/
IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://ipostatus.kfintech.com/
Accretion Nutraveda IPO FAQs
What is Accretion Nutraveda IPO?
When Accretion Nutraveda IPO will open for subscription?
What is Accretion Nutraveda IPO Investors Portion?
How to Apply the Accretion Nutraveda IPO?
What is Accretion Nutraveda IPO Issue Size?
What is Accretion Nutraveda IPO Price Band?
What is Accretion Nutraveda IPO Lot Size?
What is the Accretion Nutraveda IPO Allotment Date?
What is the Accretion Nutraveda IPO Listing Date?
Note: The Accretion Nutraveda IPO price band and date are officially announced. The (Accretion Nutraveda IPO grey market premium) will be added to the IPO GMP page as it will start).
